Patents by Inventor Christian Korfhage

Christian Korfhage has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240158836
    Abstract: The technology provided herein relates to high resolution multiplex methods and kits for detecting different analytes in a sample in parallel by sequential signal-encoding of said analytes, wherein the method allows a differentiation of targets which distance is below the diffraction limit of optical microscopes, that is, targets with spatial optical overlap. The disclosed methods also include in vitro methods for screening, identifying and/or testing a substance and/or drug and in vitro methods for diagnosis of a disease, and an optical multiplexing system.
    Type: Application
    Filed: June 29, 2023
    Publication date: May 16, 2024
    Applicant: Resolve Biosciences GmbH
    Inventors: Cheng Frank ZHONG, Christian Korfhage, Frank Reinecke, Stephan Tirier
  • Publication number: 20230227907
    Abstract: The technology provided herein relates to multiplex methods and kits for detecting different analytes in a sample in parallel by sequential signal-encoding of said analytes, as well as in vitro methods for screening, identifying and/or testing a substance and/or drug and in vitro methods for diagnosis of a disease, and an optical multiplexing system.
    Type: Application
    Filed: June 18, 2021
    Publication date: July 20, 2023
    Applicant: Resolve BioSciences GmbH
    Inventors: Andreas Geipel, Frank Reinecke, Christian Korfhage
  • Publication number: 20220235402
    Abstract: The present invention is directed to a method of sequential signal-encoding of analytes in a sample, a use of a set of decoding oligonucleotides to sequentially signal-encode analytes in a sample, and to a kit for sequentially signal-encoding of analytes in a sample.
    Type: Application
    Filed: June 18, 2020
    Publication date: July 28, 2022
    Applicant: RESOLVE BIOSCIENCES GMBH
    Inventors: Andreas GEIPEL, Frank REINECKE, Christian KORFHAGE, Nadine JAGEMANN, Vanessa MOELLERING
  • Publication number: 20220205028
    Abstract: The technology provided herein relates to multiplex methods and kits for detecting different analytes and different subgroups/variations of an analyte in a sample, for example in parallel by sequential signal-encoding of said analytes, as well as in vitro methods for screening, identifying and/or testing a substance and/or drug and in vitro methods for diagnosis of a disease, and an optical multiplexing system.
    Type: Application
    Filed: December 17, 2021
    Publication date: June 30, 2022
    Applicant: Resolve Biosciences GMBH
    Inventors: Andreas GEIPEL, Christian KORFHAGE, Frank REINECKE
  • Patent number: 11220705
    Abstract: The present invention is directed to a method for immobilizing nucleic molecule on solid support and to a use of a nucleic acid non-immobilized primer in combination with a nucleic acid primer linked to a solid support in said a method.
    Type: Grant
    Filed: April 25, 2016
    Date of Patent: January 11, 2022
    Assignee: QIAGEN GmbH
    Inventors: Christian Korfhage, Evelyn Fricke
  • Patent number: 11085073
    Abstract: The present invention is directed to a method for immobilizing a nucleic acid molecule on a solid support and to a use of a combination of a first nucleic acid immobilized primer linked to a solid support and a second immobilized primer linked to said solid support in said method.
    Type: Grant
    Filed: April 25, 2016
    Date of Patent: August 10, 2021
    Assignee: QIAGEN GmbH
    Inventors: Christian Korfhage, Evelyn Fricke
  • Patent number: 10087482
    Abstract: The present invention relates to a reaction mixture for the amplification of nucleic acids, the non-methylated cytosine bases of which have been converted to uracil bases by means of a bisulfition reaction. The invention also discloses methods for amplifying bisulfited nucleic acid and for determining the nucleic acid methylation state, and also kits based on the reaction mixture according to the invention.
    Type: Grant
    Filed: February 6, 2009
    Date of Patent: October 2, 2018
    Assignee: QIAGEN GMBH
    Inventors: Christian Korfhage, Dirk Loeffert, Ralf Peist, Nicolas Rudinger
  • Publication number: 20180112251
    Abstract: The present invention is directed to a method for immobilizing nucleic molecule on solid support and to a use of a nucleic acid non-immobilized primer in combination with a nucleic acid primer linked to a solid support in said a method.
    Type: Application
    Filed: April 25, 2016
    Publication date: April 26, 2018
    Inventors: Christian KORFHAGE, Evelyn FRICKE
  • Publication number: 20180105871
    Abstract: The present invention is directed to a method for immobilizing a nucleic acid molecule on a solid support and to a use of a combination of a first nucleic acid immobilized primer linked to a solid support and a second immobilized primer linked to said solid support in said method.
    Type: Application
    Filed: April 25, 2016
    Publication date: April 19, 2018
    Inventors: Christian Korfhage, Evelyn Fricke
  • Publication number: 20180087099
    Abstract: The present invention is directed to a method for hybridizing a nucleic acid molecule to another nucleic acid molecule and to a use of a nucleic acid molecule to reduce and/or avoid the formation of hairpin structures of a nucleic acid target molecule.
    Type: Application
    Filed: April 25, 2016
    Publication date: March 29, 2018
    Inventors: Christian KORFHAGE, Evelyn FRICKE
  • Patent number: 9777316
    Abstract: What is described is a method for quantitative and qualitative analysis of complex template nucleic acids to be analyzed. The method comprises the co-amplification of a control nucleic acid with the complex template nucleic acid by means of isothermal strand displacement reaction. The method of the invention further comprises the determination of the amount of amplified control nucleic acid as measure for the determination of the quantity and/or quality of the complex template nucleic acid used. The present invention also relates to a kit for carrying out a method of the invention. Furthermore, the use of the method of the invention or the kit of the invention for standardization of whole-genome, whole-transcriptome and whole-bisulfitome analyses is described.
    Type: Grant
    Filed: June 3, 2010
    Date of Patent: October 3, 2017
    Assignee: QIAGEN STRASSE 1
    Inventors: Christian Korfhage, Evelyn Fisch
  • Patent number: 9683255
    Abstract: The present invention concerns a method for activating a nucleic acid for a polymerase reaction with the steps: (a) Heating a nucleic acid to a temperature of 55° C. to 80° C., (b) cooling the nucleic acid to a temperature at which a polymerase shows no substantial decrease in activity, and (c) starting the polymerase reaction by the addition of a heat-labile polymerase to the nucleic acid.
    Type: Grant
    Filed: September 11, 2006
    Date of Patent: June 20, 2017
    Assignee: QIAGEN GMBH
    Inventors: Christian Korfhage, Dirk Löffert
  • Patent number: 9611506
    Abstract: This invention relates to a process for synthesis of a cDNA in a sample, in an enzymatic reaction, whereby the process comprises the steps: simultaneous preparation of a first enzyme with polyadenylation activity, a second enzyme with reverse transcriptase activity, a buffer, at least one ribonucleotide, at least one deoxyribonucleotide, an anchor oligonucleotide; addition of a sample that comprises a ribonucleic acid; and incubation of the agents of the previous steps in one or more temperature steps, which are selected such that the first enzyme and the second enzyme show activity. The invention further relates to a reaction mixture that comprises a first enzyme with polyadenylation activity, a second enzyme with reverse transcriptase activity, optionally a buffer, optionally at least one ribonucleotide, optionally at least one deoxyribonucleotide, and optionally an anchor oligonucleotide. Moreover, the invention relates to a kit that comprises a corresponding reaction mixture.
    Type: Grant
    Filed: November 12, 2015
    Date of Patent: April 4, 2017
    Assignee: QIAGEN, GMBH
    Inventors: Holger Engel, Subrahmanyam Yerramilli, Martin Kreutz, Dirk Loeffert, Christian Korfhage
  • Publication number: 20160130634
    Abstract: This invention relates to a process for synthesis of a cDNA in a sample, in an enzymatic reaction, whereby the process comprises the steps: simultaneous preparation of a first enzyme with polyadenylation activity, a second enzyme with reverse transcriptase activity, a buffer, at least one ribonucleotide, at least one deoxyribonucleotide, an anchor oligonucleotide; addition of a sample that comprises a ribonucleic acid; and incubation of the agents of the previous steps in one or more temperature steps, which are selected such that the first enzyme and the second enzyme show activity. The invention further relates to a reaction mixture that comprises a first enzyme with polyadenylation activity, a second enzyme with reverse transcriptase activity, optionally a buffer, optionally at least one ribonucleotide, optionally at least one deoxyribonucleotide, and optionally an anchor oligonucleotide. Moreover, the invention relates to a kit that comprises a corresponding reaction mixture.
    Type: Application
    Filed: November 12, 2015
    Publication date: May 12, 2016
    Inventors: Holger ENGEL, Subrahmanyam Yerramilli, Martin Kreutz, Dirk Loeffert, Christian Korfhage
  • Patent number: 9217173
    Abstract: This invention relates to a process for synthesis of a cDNA in a sample, in an enzymatic reaction, wherein the process comprises the steps: simultaneous preparation of a first enzyme with polyadenylation activity, a second enzyme with reverse transcriptase activity, a buffer, at least one ribonucleotide, at least one deoxyribonucleotide, an anchor oligonucleotide; addition of a sample that comprises a ribonucleic acid; and incubation of the agents of the previous steps in one or more temperature steps, which are selected such that the first enzyme and the second enzyme show activity. The invention further relates to a reaction mixture that comprises a first enzyme with polyadenylation activity, a second enzyme with reverse transcriptase activity, optionally a buffer, optionally at least one ribonucleotide, optionally at least one deoxyribonucleotide, and optionally an anchor oligonucleotide. Moreover, the invention relates to a kit that comprises a corresponding reaction mixture.
    Type: Grant
    Filed: August 13, 2007
    Date of Patent: December 22, 2015
    Assignee: QIAGEN GMBH
    Inventors: Holger Engel, Subrahmanyam Yerramilli, Martin Kreutz, Dirk Loeffert, Christian Korfhage
  • Patent number: 9133508
    Abstract: A method is disclosed for improved isothermal amplification of nucleic acids comprising the step of release of an essential component from a matrix under predetermined conditions. Furthermore, the invention relates to a kit comprising mesophilic enzyme and a matrix with embedded essential components for isothermal amplification. A composition comprising a matrix and a mesophilic enzyme and a method for embedding a mesophilic enzyme are disclosed as well.
    Type: Grant
    Filed: August 9, 2011
    Date of Patent: September 15, 2015
    Assignee: Qiagen GmbH
    Inventor: Christian Korfhage
  • Patent number: 9074248
    Abstract: It has been unexpectedly and surprisingly found that Helicase Dependent Amplification (HDA) primers having termini enriched for A or C at the 5?-ends, result in a much more efficient HDA reaction than those primers having G or T rich 5?-ends. Since A is a low melting base and C is a high-melting base, the melting characteristic of primer termini is not correlated with melting characteristics of amplicon termini. Optimized HDA primers, methods of making and using optimized primers, as well as methods of as well as kits for optimized HDA are disclosed.
    Type: Grant
    Filed: December 18, 2012
    Date of Patent: July 7, 2015
    Assignee: QIAGEN GMBH
    Inventors: Christian Korfhage, Sven van Ooyen
  • Patent number: 9005933
    Abstract: The present invention relates to a method for amplifying a template nucleic acid, wherein the method comprises amplifying said template nucleic acid using the helicase dependent amplification (HDA) reaction in the presence of a nicking endonuclease, and wherein said template nucleic acid comprises a sequence recognized by said nicking endonuclease or a sequence recognized by said nicking endonuclease is introduced into the template nucleic acid during the HDA reaction. The invention further pertains to a kit for amplifying a nucleic acid, comprising a nicking endonuclease, a helicase and a DNA polymerase.
    Type: Grant
    Filed: August 16, 2011
    Date of Patent: April 14, 2015
    Assignee: Qiagen GmbH
    Inventors: Christian Korfhage, Gerd Grosshauser, Thomas Rothmann, Ralf Himmelreich
  • Patent number: 8932831
    Abstract: The present invention concerns a method for inserting one or more tag sequences into a nucleic acid characterized by the following steps: (a) preparation of a template nucleic acid; (b) hybridization of at least one anchor sequence of at least one anchor oligonucleotide with one sequence section of the template nucleic acid; and (c) synthesization of a new strand of nucleic acid, which is partially complementary to the template nucleic acid and which contains a sequence complementary to the non-hybridized portion of the anchor oligonucleotide, e.g. to at least one tag sequence, on its 3? end.
    Type: Grant
    Filed: May 4, 2007
    Date of Patent: January 13, 2015
    Assignee: Qiagen GmbH
    Inventors: Christian Korfhage, Holger Engel, Dirk Löffert, Ralf Peist
  • Patent number: 8785120
    Abstract: The invention generally provides a method for the sample preparation for a subsequent preparation, processing or analysis method of a sample containing an at least one species of nucleic acid and/or one species of protein, whereby the method comprises the following steps: A) providing a sample which contains at least one species of a nucleic acid and/or of a protein, B) contacting the sample with a fluid or solid composition to produce a fluid sample preparation, whereby the composition contains at least a nitrogenous compound, which is selected from the group consisting of a) polyamines, b) amino acids, and oligo- and polypeptides, c) nitrogenous heterocyclic compounds, including homo-oder heteropolymeres, which comprise these nitrogenous compounds, d) amines of the type R1R2NR3, whereby R1, R2 and R3 are chosen independently from one another from the group consisting of H, C1-C5-alkyl groups and aryl groups, whereby R1, R2 and R3 are not H simultaneously, e) carbonxylic acid amides, f) inorganic ammonium sa
    Type: Grant
    Filed: August 24, 2010
    Date of Patent: July 22, 2014
    Assignee: Qiagen GmbH
    Inventors: Christian Korfhage, Friederike Wilmer, Dirk Loffert, Ralf Himmelreich, Claudia Fritz, Kathleen Rieske